Awards
- Officer of the British Empire (OBE), HM Queen Elizabeth II, 2008
External Positions
- International External Review Panel, Donders Institute, 2013
- Chair, NC3R Imaging Technology Development Panel and Symposium, 2013
- Hon. Vice President, London Healthcare Initiative, Korean Health Industry Development Initiative, 2013
- Steering Committee, Multiple Sclerosis Outcomes Assessment Committee, Critical Path Institute, USA, 2013
- UK Dementia Platform, 2013
- Japan Science and Technology Research Council-MRC Committee for Bilateral Science, 2012
- Chair, Imaging Sub-Panel, MRC Advanced Translational Training Panel, MRC, 2012
- MRC Committee for Bilateral Science, Japan Science and Technology Research Council, 2012
- Working Party on Genomics, Health Records, Database Linkage and Privacy, Nuffield Council on Bioethics, 2012
- BBSRC, MRC and Wellcome Trust 'Post-Weatherall' 10 year Review Committee on Non-human Primates Research, 2011
- EPSRC Medical Imaging Technologies Review Working Group, 2011
- Steering Committee, UK Biobank and Chair, Imaging Enhancements Working Group, 2011
- International Steering Committee, Clusters of Excellence in Neurodegeneration (COEN) Research Network, 2011
- NC3R Working Group on Metrics, 2011
- Chair, National Imaging Consortia Competition, Canadian Institutes of Health Sciences, 2011
- Sub-Panel 4: Neurosciences, Research Excellence Framework (REF), 2011
- British Neurosciences Association Scientific Advisory Group, 2010
- International Jury, Wiener Wissenschafter-, Forschungs- and Technologies- Fond, 2010
- Impact Pilot Panel, Research Excellence Framework (REF), 2010
- International Scientific Advisory Panel, Oxford Parkinson’s Disease Group, 2009
- MRC Industrial Collaborative Training and Career Panel, 2009
- Research Strategy Group, MS Society of Great Britain/Northern Ireland, 2009
- Special working group for national review of imaging strategy, Canadian Institutes of Health Sciences, 2009
- UK Biobank Imaging Enhancements Working Group, 2009
- Working Group on Stratified Medicines, Association of British Pharmaceutical Industries, 2009 - 2010
- MRC NMHB SPOG PET Strategy Group, 2008
- MRC Translational Medicine Group, 2008 - 2010
- MRC NMHB SPOG Addiction Strategy Steering Group, 2007
- MRC Toxicology Unit National Training Scheme Steering Committee, 2007 - 2009
- Co-chair, MRC-GSK Complex Genetics Initiative, 2007 - 2009
- MRC Experimental Medicine Panel, 2006
- MRC Neurosciences and Mental Health Strategic Portfolio Oversight Group (SPOG), 2006 - 2008
- Strategy Advisory Board, MS Society of Great Britain/Northern Ireland, 2006 - 2008
- Member, European Dana Alliance, 2004
- MRC Neurosciences and Mental Health Board, 2004 - 2010
Membership of Professional Bodies
- Full member, American Association of Neurologists, 1990
- Member, British Neurological Association
Links with Other Academic Bodies
- Visiting Professor, Department of Clinical Neurology, University of Oxford, 2010
- Hon. Professor, Institute of Neurology, University College London, 2008
- Fellow by Special Election, St Edmund Hall, University of Oxford, 1997
- Fellow by Special Election, St. Edmund Hall, University of Oxford, 1997
- Adjunct Professor of Neurology, McGill University, 1996
Industrial Connections
- GlaxoSmithKline, Vice President, Medicines Discovery and Development
- Imperial College Academic Health Sciences Centre, Hammersmith Hospital, London, Hon. Consultant Neurologist
Fellowships
- Fellow, Royal College of Physicians, 2000
- Clinical Professor, Medical Research Council (UK), 1998 - 2005
- Clinical Reader, Medical Research Council (UK), 1995 - 1998
- Clinician Scientist, Medical Research Council of Canada, 1990 - 1995
- Doctoral Training Fellow, National Science Foundation, USA, 1979 - 1982
Editorial Boards
- Neuroimage: Clinical, Board member, 2012
- Nature Reviews Neuroscience
- Faculty of 1000: Medicine